课题基金 / 基金详情

项目摘要

项目成果

Ram Savan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary The goal of this proposal is to investigate a novel role of CELF2 in suppressing interferon responses to self- RNA ligands. While interferons (IFN) induced by non-self-viral RNA activate an antiviral program to restrict viral pathogens, their aberrant expression can cause tissue damage leading to autoimmunity. Although the toll-like receptors and RIG-I-like receptors normally sense non-self RNA, these sensors are also activated by self-RNA under certain conditions. Recognition of self-RNA can be a consequence of a failure of the suppression of the self-RNA ligands. RNA editing by ADAR1 is one pathway used to suppress self-RNA ligands, but it is conceivable that there are many other mechanisms that suppress endogenous immunostimulatory RNA ligands. We made a surprising observation that the loss of splicing factor CELF2 induced a robust induction of type I IFN and IFN-stimulated genes. Splicing factors are required for mRNA processing and post- transcriptional regulation, however the effect of aberrant and alternative splicing on IFN responses is understudied. We found that IFN induced during CELF2 depletion is dependent on RIG-I-like receptors. In this proposal, we will identify the mechanisms of CELF2-mediated suppression of IFN activation. CELF2 has not been previously implicated in suppressing immunostimulatory self-RNA ligands. This study will describe a novel role for CELF2 in innate immune signaling, but also study the effect of perturbation of mRNA splicing on innate immunity. This study has the potential to uncover mechanisms of the biogenesis of endogenous RNA that activates the RLR pathway. These findings could have a significant impact on understanding IFN-induced immune pathologies and identify new therapeutic targets in autoimmunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prenylation in antiviral immunity
  • 批准号:
    10647533
  • 项目类别:
  • 资助金额:
    $64.66万
  • 财政年份:
    2023
  • 负责人:
    Ram Savan
  • 依托单位:
Regulation of cardiomyocyte inflammation during viral infection
  • 批准号:
    10244888
  • 项目类别:
  • 资助金额:
    $22.39万
  • 财政年份:
    2020
  • 负责人:
    Ram Savan
  • 依托单位:
Regulation of cardiomyocyte inflammation during viral infection
  • 批准号:
    9894164
  • 项目类别:
  • 资助金额:
    $28.28万
  • 财政年份:
    2020
  • 负责人:
    Ram Savan
  • 依托单位:
Translational Reprogramming by Regulatory T Cells
国内基金
海外基金
ADAR1抑制Z-DNA累积激活cGAS-STING信号通路并诱导中性粒细胞产生胞外诱捕网引起鼻咽癌放疗抵抗的机制
  • 批准号:
    2025JJ50711
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    王芙艳
  • 依托单位:
诱导型ADAR1通过DNA-RNA杂合体堆积持续启动滞育样重编程介导舌鳞癌细胞休眠的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    李静远
  • 依托单位:
ADAR1通过miR-181a-5p-ESM1信号调控母胎界面血管重铸的分子机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    陈慧
  • 依托单位:
肿瘤相关巨噬细胞诱发ADAR1介导的A-to-I编辑调控pri-miRNA的成熟在骨肉瘤侵袭转移中的作用及机制研究
  • 批准号:
    82373051
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    鲍兴
  • 依托单位: